세계의 인간 1대 세포 배양 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Human Primary Cell Culture Market Growth & Trends:

The global human primary cell culture market is anticipated to reach USD 7.15 billion by 2030 and grow at a CAGR of 11.05% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the primary cell culture market can be attributed to several key factors including the increasing demand for monoclonal antibodies, a rise in cancer research initiatives, the expanding number of pharmaceutical and biotechnology companies, the growing advantages of primary human cells over established cell lines, and increased government support for cell-based research.

Monoclonal antibodies have become central to various therapeutic applications due to their high specificity and effectiveness in targeting specific antigens. Primary cells play a critical role in developing and testing these antibodies, driving their demand in the market. The pharmaceutical and biotechnology industries, which rely heavily on primary cells for drug discovery, toxicity testing, disease modeling, and personalized medicine, are also experiencing significant growth. The shift toward precision medicine and targeted therapies has amplified the demand for primary cells in research and development activities, making them indispensable in advancing modern healthcare solutions.

Another significant factor propelling the market is the increasing demand for more effective models to study infectious diseases. The COVID-19 pandemic has heightened awareness around the need for accurate models to test vaccine candidates, antiviral drugs, and other therapeutic solutions. Human primary cell cultures are particularly suited for studying viral infections, as they closely mimic human tissue responses, which is critical in developing new vaccines and treatments for diseases like HIV, hepatitis, and influenza. Additionally, their ability to replicate the behavior of immune cells makes them essential in understanding immune responses and host-pathogen interactions.

While primary cells offer a more biologically relevant model for research than cell lines, their high cost can limit their accessibility. Procuring human primary cells often involves sourcing from specialized biorepositories or commercial vendors, and these cells can be considerably more expensive than established cell lines.

Human Primary Cell Culture Market Report Highlights:

• Based on product, the primary cells segment held the largest market share in 2024. The rising demand for personalized medicine, technological advancements in 3D culture, organ-on-chip platforms, and microfluidic systems, and the rising focus on drug discovery and toxicology testing drive the segment's growth.
• Based on application, the therapy development segment dominated the market with a share in 2024. Primary cells are essential for producing biologics, monoclonal antibodies, and vaccines. Moreover, the pandemic demonstrated the critical role of cell culture in virology, driving sustained investment.
• Based on end use, the pharmaceutical & biotechnology companies segment dominated the market in 2024. The pharmaceutical and biopharmaceutical industries are witnessing substantial growth in the market, driven by the growing adoption of cell-based models for drug discovery, development, and manufacturing.
• The North American region dominated the market share of 41.12% in 2024. North America's human primary cell culture industry is experiencing significant growth, driven by several key factors. A major contributor is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which has led to a surge in research activities utilizing primary cell cultures for drug discovery and development.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Type Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
    • 3.2.1.2. Growing focus on personalized medicine
    • 3.2.1.3. Technological innovations in 3D cell culture
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of primary cells
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Primary Cell Culture Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Human Primary Cell Culture Market Product Movement Analysis
• 4.3. Global Human primary cell culture market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Primary Cells
  • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Hematopoietic Cells
    • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Skin Cells
    • 4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Hepatocytes
    • 4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Gastrointestinal Cells
    • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Lung Cells
    • 4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Renal Cells
    • 4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.8. Heart Cells
    • 4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.9. Skeletal and Muscle Cells
    • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.10. Other Primary Cells
    • 4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Primary Cell Culture Media
  • 4.5.1. Global Primary Cell Culture Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Serum-free Media
    • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Serum-containing Media
    • 4.5.3.1. Global Serum-contaning Media Market and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Other Media
    • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Reagents and Supplements
  • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Attachment Solutions
    • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Buffers and Salts
    • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. Sera
    • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Growth Factors and Cytokines
    • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Human Primary Cell Culture Market Application, Movement Analysis
• 5.3. Global Human primary cell culture market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Discovery
  • 5.4.1. Global Drug Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Therapy Development
  • 5.5.1. Global Therapy Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Regenerative Medicine
  • 5.6.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Other Applications
  • 5.7.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture Market: End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Human Primary Cell Culture Market End Use Movement Analysis
• 6.3. Global Human primary cell culture market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. CMOs & CROs
  • 6.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Academic Research Institutes
  • 6.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Australia Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Thailand Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. South Korea Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Participant's Overview
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. STEMCELL Technologies
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Merck KGaA
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Lonza
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Cell Biologics, Inc.
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. PromoCell GMBH
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. ZenBio
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. AllCells
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. American Type Culture Collection
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Axol Biosciences Ltd.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives